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Abstract X chromosome inactivation (XCI) is a process
in mammals that ensures equal transcript levels between
males and females by genetic inactivation of one of the two
X chromosomes in females. Central to XCI is the long non-
coding RNA Xist, which is highly and specifically
expressed from the inactive X chromosome. Xist covers the
X chromosome in cis and triggers genetic silencing, but its
working mechanism remains elusive. Here, we review
current knowledge about Xist regulation, structure, func-
tion and conservation and speculate on possible mecha-
nisms by which its action is restricted in cis. We also
discuss dosage compensation mechanisms other than XCI
and how knowledge from invertebrate species may help to
provide a better understanding of the mechanisms of
mammalian XCI.
Introduction
In placental mammals, individuals carrying an X and a Y
chromosome develop as males, whereas XX animals
develop as females. The Y chromosome contains only a
small number of genes, most of them male-specific. The X
chromosome, in contrast, contains around 1,000 genes,
posing an enormous copy number imbalance between the
sexes. The potentially detrimental effects of copy number
imbalances are evidenced by autosomal copy number
changes, which invariably result in embryonic lethality or
severe developmental defects. Nevertheless, the twofold
difference in X chromosome number between males and
females is part of normal development, and inheritance of
aberrant X copy numbers (as in e.g. XXX or XO females,
or XXY males) results in phenotypes that are relatively
mild compared with autosomal aneuploidy. The reason for
this exceptional behavior of X chromosomes is that, while
an X- and Y-chromosomal system evolved to discriminate
between the sexes, dosage compensation mechanisms
co-evolved to counteract the detrimental effects of the asso-
ciated copy number variations in hundreds of X chromo-
somal genes.
Dosage compensation is a mechanism that corrects for
the sex-chromosomal dosage differences between the sexes.
In 1961, Mary Lyon was one of the first to suggest that
dosage compensation in mice occurs by genetic inactivation
of one of the two X chromosomes in female cells (Lyon
1961). Earlier studies had reported that nerve cell nuclei
from female cats have one chromosome that is structurally
distinct and characterized by distinct nuclear morphology
visible as a dense heterochromatic region, also known as the
Barr body (Barr and Bertram 1949). Other experiments
revealed that in female rat liver cells, the Barr body repre-
sents one X chromosome whereas the other appears
euchromatic like the autosomes (Ohno et al. 1959). Fur-
thermore, mice with a single X chromosome (XO) were
found to be phenotypically normal, suggesting that one X is
sufficient for normal viability (Welshons and Russell 1959).
Lyon suggested that one of the two X chromosomes in
female mice is subject to genetically programmed, random
inactivation. This theory was supported by the mosaic
appearance of female mice that are heterozygous for an
X-linked fur color gene: random inactivation of one X
chromosome in each cell in the early embryo, followed by
clonal expansion accounts for this observation (Lyon 1961).
X chromosome inactivation (XCI) in females thus leads
to similar transcription levels of X-chromosomal genes
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between males and females, who now both express genes
from a single X chromosome. However, not all genes on
the X are inactivated: genes in the pseudo-autosomal
region (PAR), the region of the X homologous to the Y and
responsible for XY-pairing during meiosis, as well as a fair
number of individual genes on the X are not inactivated.
The latter genes are called escapers and it has been esti-
mated that 15–20% of human X-linked genes completely
escape inactivation, and another 10% escape partially
(Carrel and Willard 2005). PAR genes are expressed from
two copies in both males and females, whereas escapers
that lack a functional Y homolog are differentially
expressed between the sexes. The PAR genes together with
the escapers likely account for the phenotypes observed in
for example XO and XXX females.
XCI occurs in all marsupials and placental mammals
during early development. Interestingly, XCI is not the
only solution to compensate for sex chromosome dosage
differences; other species have developed completely dif-
ferent approaches to solve the same problem (Fig. 1a–d).
In the fruit fly Drosophila melanogaster, male (XY) indi-
viduals increase expression of their single X chromosome
twofold to meet expression levels of their female (XX)
counterparts (Gelbart and Kuroda 2009). In the nematode
Caenorhabditis elegans, males have a single X chromo-
some (XO) and XX individuals are hermaphrodites. Here,
XX hermaphrodites reduce transcription levels from both X
chromosomes by half to achieve similar transcription levels
as in XO males (Meyer et al. 2004). Despite the different
approaches, mice, worms and flies have in common that in
Fig. 1 Mammalian, Caenorhabditis elegans and Drosophila mela-
nogaster dosage compensation. a Table comparing features of dosage
compensation between the three species. Proteins indicated with an
asterisk are not specific for dosage compensation and are also a part
of other complexes or cellular processes. b–d Images showing X
chromosome-wide localization of dosage compensation components.
b Mouse differentiating ES cell; the inactive X chromosome is coated
by Xist RNA (green; RNA FISH for Xist). c Both X chromosomes in
a C. elegans embryonic hermaphrodite nucleus are bound by the
dosage compensation complex (DCC) (green; DCC component DPY-
27, courtesy of Te Wen Lo and Barbara J. Meyer). d Male Drosophila
cell with polytene chromosomes, showing the DCC targeting the X
chromosome in green (green; DCC component MSL2, courtesy of Ina
Dahlsveen and Peter Becker)
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one sex, specialized, X-specific complexes (dosage com-
pensation complex, DCC) composed of RNA and/or pro-
tein target an entire chromosome for stable and inheritable
changes in transcription levels through epigenetic modifi-
cations (Fig. 1a–d).
In this review, we discuss what is currently known about
the initiation and establishment of XCI in placental mam-
mals. We focus on the role of Xist, XCI’s central player,
and briefly discuss how knowledge from invertebrate spe-
cies may help to gain new insight in mammalian dosage
compensation.
XCI initiation
In mice, XCI is initiated in the early embryo in two rounds.
At an early developmental stage, around the 4- to 8-cell
stage, the paternal X chromosome is inactivated in all cells
of the developing embryo (imprinted XCI) (Huynh and Lee
2003; Okamoto et al. 2004). Later in development, this
chromosome becomes reactivated in the inner cell mass,
but remains inactive in the extra-embryonic tissues. A
second round of XCI then occurs in the developing embryo
proper around embryonic day 5.5. In inbred mouse strains,
the choice of the X to be inactivated is random this time;
the paternal and maternal X chromosomes now have equal
chances of becoming inactivated (random XCI). In inter-
species crosses, preferred inactivation of either the paternal
or maternal X chromosome (skewing) may occur. Once the
choice of the X chromosome to inactivate has been made,
the inactive X is propagated clonally to daughter cells.
Xist and Tsix, the master regulators of X inactivation
Central to XCI in mammals is the long, non-coding RNA
Xist (X-inactive specific transcript). It is transcribed from
the Xist gene, which lies in a region on the X chromosome
called the X inactivation center (Xic), containing clustered
genes and regulatory sequences involved in the X inacti-
vation process (Fig. 2a). Xist is spliced and polyadenylated
and, during XCI onset, becomes transcribed only from the
future inactive X chromosome (Xi) (Borsani et al. 1991;
Brockdorff et al. 1991, 1992; Brown 1991). The processed
Xist transcript coats the Xi in cis (Brown et al. 1992) and
recruits chromatin remodeling complexes including PRC2,
which trimethylates lysine 27 on histone H3 (H3K27me3),
a hallmark of facultative heterochromatin (Chadwick and
Willard 2004; Mak et al. 2002; Plath et al. 2003; Silva et al.
2003; Zhao et al. 2008). Xist is absolutely essential for
initiation of XCI and covers the Xi in all differentiated
somatic cells, resulting in Xist RNA associating with the
Xi, forming typical ‘‘clouds’’ when visualized by RNA
FISH (Fig. 1b) (Brown et al. 1992). Once the Xi has been
completely silenced, the silent state is stably inherited and
can not be reversed. Tight regulation of Xist transcription
to ensure inactivation of a single X chromosome only in
females is, therefore, essential.
In mice, antagonizing Xist function is Tsix RNA, which
is transcribed in the antisense orientation from Xist and
fully overlaps with the Xist gene (Fig. 2a) (Lee et al. 1999).
Tsix is also a non-coding RNA, is transcribed from the
active X (Xa) before and during XCI onset (Lee et al.
1999), and inhibits Xist expression in cis by several
mechanisms. First, inhibition may occur by transcriptional
interference (Luikenhuis et al. 2001; Sado et al. 2006;
Shibata and Lee 2004). Second, Xist/Tsix duplex RNA
formation and processing by the RNA interference pathway
may play a role by siRNA-mediated deposition of chro-
matin remodeling complexes (Ogawa et al. 2008). Also,
recruitment of chromatin remodeling complexes by the
Tsix RNA to the Xist promoter has been postulated as a
possible mechanism for Tsix-mediated repression of Xist
(Sun et al. 2006). Finally, Tsix is involved in pairing of the
two X chromosomes, a process which has been implicated
in initiation of XCI (Bacher et al. 2006; Xu et al. 2006).
Deletion or truncation of Tsix leads to up-regulation of Xist
in cis and skewed XCI with preferential inactivation of the
mutated allele (Lee and Lu 1999). Impaired transcription of
Tsix has also been reported to lead to ectopic XCI in male
cells (Luikenhuis et al. 2001; Sado et al. 2002; Vigneau
et al. 2006), although one study indicated absence of XCI
in Tsix mutant male ES cells (Lee and Lu 1999). The
discrepancy between these studies is most likely caused by
differences in differentiation protocols which has recently
been shown to lead to altered expression levels of key XCI
regulators, including OCT4 (Ahn and Lee 2010).
Xist and Tsix are the master regulatory switch genes in
XCI. Interestingly, in female cells with a heterozygous
deletion encompassing both genes that includes Xite, a
positive regulator of Tsix located upstream of Tsix, XCI is
still initiated on the wild type X chromosome (Monkhorst
et al. 2008). This suggests that activation of Xist is regu-
lated by other factors, but how? In C. elegans, autosomal
and X-linked regulators play a key role in the counting
process, by determining the relative number of X chro-
mosomes. Here, initiation of dosage compensation is
determined by the balance between autosomal and
X-chromosomal signal elements (Powell et al. 2005).
X-linked activators thus counteract the effect of autosomal
inhibitors of dosage compensation. When the ratio of
X-linked versus autosomal signal elements is 1, as in XX
hermaphrodites, the dosage compensation machinery is
turned on. However, if the ratio is lower than 1, as in XO
males (X:A ratio 0.5), the concentration of X-linked acti-
vators is not sufficient to overcome repression of the dos-
age compensation machinery by autosomal inhibitors
(Meyer 2000).
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Activators of X chromosome inactivation
Several recent findings support a role for X-linked activa-
tors and autosomally encoded inhibitors in the regulation of
mammalian XCI. The first indications came from studies
with triploid and tetraploid mouse ES cell lines generated
by cell fusion experiments. Analysis of XXXX, XXXY and
XXYY tetraploid ES cells after differentiation showed that
a single X chromosome remains active for each diploid
autosome set (Monkhorst et al. 2008; Takagi 1983, 1993),
as was found for mouse tetraploid embryos (Webb et al.
1992). Comparison of XCI kinetics in these different
Fig. 2 Features of the X-inactivation center (Xic) and Xist in mouse.
a Schematic overview of the location of the X inactivation center
(Xic) on X (top panel) and the genes contained in this region (second
panel). The third panel shows the overlapping transcripts Xist and
Tsix. Tsix has two annotated promoters, the one downstream being
the major promoter. The last panel is a schematic overview of the
Xist transcript with repetitive domains indicated in yellow (b).
Overview of the repetitive regions in Xist indicated in a
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tetraploid, and also XXY triploid ES cells, indicated an
important role for the X:A ratio in the probability to initiate
XCI, suggesting the presence of an X-encoded activator of
XCI (Monkhorst et al. 2009). The first activator, the E3
ubiquitin ligase RNF12/RLIM, was recently discovered
and is one of the few known protein-coding—rather than
RNA—regulators of Xist (Jonkers et al. 2009). The Rnf12
gene is located approximately 500 kb upstream of Xist
(Fig. 2a) and the encoded protein stimulates Xist expres-
sion in a dose-dependent manner. RNF12 expression from
a single X chromosome in males is insufficient to activate
Xist, whereas the double dose in females is sufficient to
initiate XCI. In contrast to Xist and Tsix, RNF12 acts in
trans and activates Xist on both X chromosomes. Once the
inactivation process is started on one X and silencing
spreads over the chromosome, Rnf12 will also become
silenced in cis. Given a relatively short half-life for RNF12,
this results in an RNF12 expression level that equals that in
male cells, and this is too low to activate Xist on the other
X. Because initiation of XCI is driven by stochastic pro-
cesses, and the feedback after XCI initiation is rapid, most
XX female cells will initiate XCI on a single X chromo-
some only (Monkhorst et al. 2008). As would be expected
for a trans-acting activator, overexpression of Rnf12 trig-
gers XCI in male cells and leads to inactivation of both X
chromosomes in a high percentage of female cells (Jonkers
et al. 2009). Also, only very few Rnf12-/- cells initiate
XCI (Barakat et al. 2011). A different study also reported
impaired imprinted XCI in cells carrying a maternally
inherited Rnf12 deletion, but observed a milder effect on
random XCI (Shin et al. 2010), possibly as a consequence
of differences in expression of other XCI-activators and
-inhibitors. Although the target of the E3 ubiquitin ligase
RNF12 remains elusive, transgenic studies indicate that
Xist is the major downstream target of RNF12 (Barakat
et al. 2011). Unexpectedly, XCI is skewed toward the
mutated X chromosome in Rnf12?/- female ES cells
(Barakat et al. 2011), despite the absence of a phenotype
for this mutation in male Rnf12-/Y mice (Shin et al. 2010).
This suggests that RNF12 is required for persistent Xist
expression, at least during the window when XCI is
established (Wutz and Jaenisch 2000). A continuous
requirement for RNF12 for the activation of Xist and for
maintenance of XCI may also explain why Rnf12?/-
female embryos which maternally inherit the mutated allele
display severe growth defects: maternal inheritance of the
mutated allele would result in an Rnf12 null embryo
because the wild type paternal X becomes inactivated
during imprinted XCI. Due to the complete absence of
Rnf12 expression that follows, these embryos may then be
unable to maintain Xist expression and imprinted XCI,
explaining the reported early lethality of these mice (Shin
et al. 2010).
Many other positive regulators of Xist can be found in
the Xic region and include the non-coding RNAs Ftx and
Jpx, and the pairing element Xpr (Augui et al. 2007;
Chureau et al. 2011; Sun et al. 2006; Tian et al. 2010). The
region of the Xic upstream of Xist—including Ftx, Jpx and
Xpr—has been shown to be enriched for H3K9 and H3K27
di- and trimethylation, respectively (Heard et al. 2001;
Rougeulle et al. 2004). These epigenetic marks may con-
tribute to transcriptional regulation of one or more genes in
the region, including Xist itself, and may result from
ongoing bidirectional transcription in this region as well as
from immediate recruitment of PRC2 by nascent Xist
transcripts. The Xpr region is involved in pairing of the two
X chromosomes at the onset of XCI (Augui et al. 2007).
Pairing of the Xist/Tsix region has been implicated to play
an important role in the initiation of XCI (Bacher et al.
2006; Xu et al. 2006), although a regulatory role for direct
interaction of two X chromosomes in XCI remains to be
determined.
Deletion of Ftx in male mouse ES cells is associated
with reduced transcription of Xist, Tsix and Jpx (Chureau
et al. 2011). These findings could indicate a direct role for
Ftx in Xist activation, but may also be explained by Ftx-
mediated global activation of the Xic region. A similar role
may be attributed to Jpx/Enox, which encodes another non-
coding long RNA, and is located just upstream of Xist. Jpx/
Enox has been shown to activate Xist in trans, possibly by
interfering with Tsix (Tian et al. 2010). However, unlike
Rnf12 transgenic lines, male cell lines with Ftx or Jpx/Enox
transgenes did not show induction of XCI on the endoge-
nous X chromosome (Jonkers et al. 2009), arguing against
a role in trans for these genes. Similar results were
obtained with Xpr transgenic male ES cell lines (Jonkers
et al. 2009). Nevertheless, studies with Xist YAC trans-
genic male ES cell lines covering both Ftx and Jpx/Enox
showed induction of XCI on the endogenous X chromo-
some in a small percentage of cells, but only in multicopy
ES cell lines (Heard et al. 1999). These findings suggest
that Ftx and Jpx/Enox may require additional factors for
their trans-activating properties, and also indicate that
RNF12 is a more potent activator of the XCI process.
Inhibitors of X chromosome inactivation
Other important regulators of XCI are the key pluripotency
factors NANOG, OCT4, KLF4, REX1 and SOX2, and the
reprogramming factor cMYC, acting as autosomally
encoded inhibitors of XCI (Donohoe et al. 2009; Navarro
et al. 2008, 2010). Binding of different combinations of
these pluripotency factors at different locations in the locus
can either result in repression of Xist or in activation of Tsix
or Xite. NANOG, OCT4 and SOX2 bind the intron 1 region
of Xist and binding of these factors has been implicated in
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direct repression of Xist (Navarro et al. 2008). OCT4 is also
recruited to the Tsix regulatory region, and binds the Xite
promoter region together with SOX2 (Donohoe et al.
2009). Recruitment of these factors has been implicated in
X chromosome pairing and in activation of Tsix, although
binding of OCT4 and SOX2 to these specific regions has
been disputed by others (Navarro et al. 2010). REX1,
KLF4, and cMYC are recruited to the DXPas34 region, a
regulatory region in Tsix, and are involved in Tsix activa-
tion (Navarro et al. 2010), together with YY1 and CTCF
(Donohoe et al. 2007). The repression of Xist is released
upon differentiation, as the concentration of pluripotency
factors drops, linking XCI to the pluripotent state and
differentiation (Navarro et al. 2008). Interestingly, a dele-
tion encompassing the Xist intron 1 region that recruits
OCT4, SOX2 and NANOG, only has a mild effect on XCI,
leading to skewed XCI at later stages of ES cell differen-
tiation (Barakat et al. 2011). Xist expression in undiffer-
entiated heterozygous intron 1?/- female ES cells was not
affected, indicating that ES cell specific transcription fac-
tors act in concert to inhibit Xist expression by binding to
various sites throughout the Xist, Tsix and Xite genes.
Finally, NANOG, OCT4 and SOX2 also have a repressive
effect on XCI by binding and inhibiting Rnf12 (Navarro
et al. 2011). Altogether, the inhibitors are involved in
setting a threshold that has to be overcome by the XCI-
activators to induce XCI (Barakat et al. 2010). Indeed, gene
ablation experiments of these different factors resulted in
ectopic activation of XCI in mutated male cells, supporting
a crucial role for these factors in maintaining the threshold
for XCI.
Despite this wide plethora of known XCI regulators (see
Fig. 3 for an overview), it is likely that more remain to be
identified. Evidence for undiscovered activators of XCI
comes from the observation that Rnf12?/- heterozygous
female mouse ES cells still initiate XCI, albeit at much
lower levels (Jonkers et al. 2009), and even Rnf12 null cells
still display occasional XCI (Barakat et al. 2011).
XCI establishment
As discussed above, the end result of Xist regulation is
expression from a single X chromosome in females, which
is then to become the Xi. The first observation following
Xist expression is coating of the Xi by Xist RNA, exclusion
of RNA polymerase II (polII) from the Xist compartment
(see below), and gradual accumulation of Xi-specific epi-
genetic marks.
X chromosome coating by Xist and formation
of a nuclear compartment
Spreading of Xist must be restricted to prevent the aberrant
inactivation of another X chromosome or possibly even an
autosome. Thus, Xist must act in cis and should not spread
onto other chromosomes. Xist-tagging experiments have
shown that Xist RNA never leaves the territory of the X
chromosome from which it is transcribed (Jonkers et al.
2008). How diffusion of Xist is restricted is not known, but
the Xist domain forms a distinct nuclear compartment from
which RNA polII is excluded. X chromosomal genes are
recruited into this domain and subsequently become
silenced. The formation of a compartment suggests that
structural nuclear factors play a role (Chaumeil et al. 2006;
Nakagawa and Prasanth 2011), and at least two proteins
that are thought to be components of the nuclear matrix,
Fig. 3 Overview of regulators
of Xist and XCI. Left activators
and inhibitors act through the
Xist/Tsix switch region to
regulate initiation of XCI. Right
XCI is established and
maintained by a plethora of
histone modifications, bound
protein and protein complexes,
and RNA specific for the Xi
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SAF-A and SATB1, are involved in establishing this
compartment (Nakagawa and Prasanth 2011). The nuclear
matrix is referred to as the biochemical nuclear structure
that is resistant to detergent and high salt treatment and that
remains after treatment with nucleases (Berezney 1991). Its
composition and even its mere existence are heavily
debated. Heterogeneous nuclear proteins (hnRNPs) are
important nuclear structural proteins and possible consti-
tuents of a nuclear matrix, and are thought to organize the
genome by binding to putative matrix-associated regions
(MARs) in the DNA. One such hnRNP, SAF-A, colocal-
izes with Xist and is important for the formation of the Xist
nuclear compartment (Fackelmayer 2005; Hasegawa et al.
2010; Helbig and Fackelmayer 2003; Pullirsch et al. 2010).
Cells depleted of SAF-A by RNAi fail to form Xist clouds
and show lower levels of H3K27me3 (Hasegawa et al.
2010). Another nuclear protein, SATB1—a DNA binding
protein involved in nuclear architecture and chromatin
looping (Cai et al. 2003, 2006)—also contributes to the
framework of the Xist compartment (Agrelo et al. 2009).
Although Xist and SatB1 do not colocalize or interact
directly, SATB1 forms a ring-like structure that contains
Xist RNA in thymic cells. SATB1 is required for correct
localization of Xist because SATB1 knockdown leads to
impaired formation of Xist clouds in these cells (Agrelo
et al. 2009). The expression pattern of this protein overlaps
with the permissive window of XCI initiation, and over-
expression of SatB1 together with Xist in differentiated
cells allows gene silencing to occur (Agrelo et al. 2009).
The structural function of SAF-A and SATB1 suggests that
they contribute to XCI through the formation of the silent
nuclear compartment. A role for nuclear structural proteins
is further supported by the finding that the compartment is
formed independently of DNA, since DNase treatment
does not disrupt the Xist localization pattern (Clemson
et al. 1996). However, the nature of the molecular inter-
actions between SAF-A, SATB1 and Xist remain to be
determined.
The Xist nuclear compartment is depleted of RNA polII,
and initial gene silencing is established by relocalization of
active genes into this RNA polII-depleted area, followed by
the epigenetic modifications that contribute to long-term
silencing (Chaumeil et al. 2006). Thus, genes cease to be
transcribed before the appearance of silent chromatin
marks such as H3K27me3. Interestingly, it was recently
shown that lack of transcription is sufficient to trigger
chromatin modifications. Treatment of cells with actino-
mycin D, which binds the transcription initiation complex
and inhibits elongation, markedly reduces the size of the
nuclear territory occupied by Xa, approaching the size of
the Xi. Nevertheless, the basal packaging of chromatin in
30 nm fibers remains unaffected. This shows that tran-
scription inhibition leads to chromatin compaction and that
this occurs at a higher level of compaction than the 30 nm
fiber (Naughton et al. 2010). Relocalization into an RNA
polII-depleted area may thus be sufficient to establish some
of the chromatin marks associated with the Xi, although
clearly factors and events are required for stable mainte-
nance of the Xi.
Epigenetic marks associated with XCI
During the establishment of the nuclear compartment,
PRC2 (polycomb repressive complex 2) is recruited to the
Xi by Xist. PRC2 is composed of the protein subunits
SUZ12, EED and EZH2, and it trimethylates lysine 27 of
histone H3 (H3K27me3), a hallmark of inactive chromatin.
This inactivating mark first appears on active genes (Marks
et al. 2009). Active genes are generally characterized by
H3K4me3 enrichment in their promoters, and the deposi-
tion of H3K27me3 here may thus result in the simultaneous
occurrence of opposing (active vs. inactive) chromatin
marks, on the Xa and Xi, or may even be present transiently
on promoters of active genes on the future Xi. Interestingly,
such a bivalent state is typical for many developmental
genes in ES cells (Azuara et al. 2006; Bernstein et al. 2006;
Pan et al. 2007; Pasini et al. 2008). Next, the H3K4me3
mark is gradually lost (Marks et al. 2009), followed by
incorporation of histone macroH2A (Costanzi and Pehrson
1998; Mermoud et al. 1999), enrichment for H3K9me2
(Heard et al. 2001; Mermoud et al. 2002; Peters et al. 2002),
ubiquitylation of H2AK119 (de Napoles et al. 2007; Smith
et al. 2004), H4K20 methylation (Kohlmaier et al. 2004),
DNA methylation (Norris et al. 1991) and hypoacetylation
of histone H4 (Jeppesen and Turner 1993) (Fig. 3). The Xi
also becomes enriched for PRC1, which is associated with
PRC2 and H3K27me3 (Plath et al. 2004). Surprisingly, Xist
is not required for the maintenance of the Xi once the
inactive state is established. Conditional deletion of Xist in
differentiated cells leads to loss of macroH2A incorporation
and loss of H3K27me3, but the Xi is not reactivated
(Csankovszki et al. 1999; Kohlmaier et al. 2004). In fact, no
conditions, except reprogramming, have been found to date
that can completely reactivate the Xi. Only harsh and highly
artificial conditions involving conditional knockout of Xist,
combined with chemical treatments that remove DNA
methylation and inhibit hypoacetylation, have been found to
lead to limited reactivation of a GFP transgene on the Xi
(Csankovszki et al. 2001). Thus, some epigenetic modifi-
cations persist in the absence of Xist and are sufficient to
maintain the inactive state.
The differential regulation of XCI initiation, establish-
ment and maintenance is further supported by the finding
that overexpression of Xist cannot induce XCI in cells once
they have differentiated (Kohlmaier et al. 2004; Wutz and
Jaenisch 2000). This led to the suggestion that stem cells
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and early embryos go through an ‘‘XCI permissive state’’
during early differentiation. Only in this time window, Xist
is required for and capable of XCI. Proteins that are key to
stem cell identity, such as OCT4, REX1, SOX2 and NA-
NOG, may play a role in defining this window, as these
also regulate Xist and Tsix expression directly and indi-
rectly (Navarro et al. 2008, 2010).
Conservation of Xist RNA structure and functional
elements
Besides a role for nuclear structural proteins in preventing
diffusion of Xist throughout the nucleus, self-aggregation
properties may also be a feature of Xist. Although pre-
dictions have been made regarding the secondary structure
of repetitive sequences in Xist, no models currently exist
for folding of the complete Xist RNA. Whether Xist’s
overall structure is conserved thus remains unknown, but
conserved sequence elements may aid in understanding the
intriguing characteristics of Xist. Poor overall sequence
conservation of Xist between mice, humans and other
mammals provides little information on functionality, and
suggests that secondary structure is more important for Xist
function than the primary sequence. In Drosophila dosage
compensation, two non-coding RNAs—roX1 and roX2—
play a central role in targeting the DCC to the X chro-
mosome (Fig. 1). Also here, secondary structure seems
important, despite these two RNAs being fully redundant;
they share almost no sequence similarity (Meller and
Rattner 2002). Nevertheless, some parts of Xist are con-
served at the sequence level, suggestive of functional ele-
ments. Some of these are highly repetitive and are referred
to as repeat A–E (Fig. 2b). In addition, the fourth exon of
Xist is well conserved.
The conserved repeat A is composed of nine A-rich
repeats and is the best characterized region of Xist (Fig. 2a,
b) (Nesterova et al. 2001). Several predictions have been
made regarding the secondary structure of this repeat, all
involving the formation of hairpin structures. It is required
for the silencing function of Xist by serving as a recogni-
tion and binding site for PRC2 (Maenner et al. 2010; Zhao
et al. 2008). Also, the region may dimerize with other
A-repeats (Duszczyk et al. 2008). It is unlikely that repeat
A contributes to aggregation and localization of Xist, since
studies using constructs expressing a mutant form of Xist
have shown that Xist localizes normally in the absence of
the A-repeat, but lacks silencing activity (Royce-Tolland
et al. 2010; Wutz et al. 2002). Others have targeted the
endogenous Xist locus for deletion of the A-repeat and
showed that this sequence is also required for Xist
expression, and deletion leads to ectopic Tsix expression in
the pre-implantation embryo (Hoki et al. 2009). Interest-
ingly, a 1.6 kb-long non-coding RNA called RepA is
transcribed from the A-repeat region. This RNA recruits
the PRC2 complex through interaction with the EZH2
subunit, and may itself be involved in the initiation of XCI
(Zhao et al. 2008).
Seemingly contradicting data have been published
regarding the role of repeat C (Fig. 2b). Wutz et al. (2002)
showed that an Xist transgene with a deletion of repeat C
localizes normally to DNA, and is also still capable of
silencing. However, another study recently reported that
blocking the same repeat C with an LNA probe (locked
nucleic acid—an antisense probe with high melting tem-
perature that stably binds the target DNA) completely
disrupts Xist localization (Sarma et al. 2010). Since dele-
tion of the same repeat does not affect localization, the
mislocalization of LNA-targeted Xist may represent an
indirect effect: the LNA may interfere with secondary
structure formation and affect the global folding of the
molecule, leading to impaired localization, whereas the
C-repeat itself is not required for localization.
The other conserved sequences in Xist are less exten-
sively characterized and seem to serve redundant functions
(Fig. 2b). Deletion of repeats B, C, D and E showed
unaffected localization patterns. Even combined deletion
of several repeats simultaneously barely affects the local-
ization pattern (Fig. 2b) (Wutz et al. 2002). Only deletion
products lacking repeat A in combination with one or more
of the other repeats show impaired localization. For repeat
B, an effect on promoter activity has been reported
(Hendrich et al. 1997). An Xist allele containing an
inversion that includes repeat D (XistINV) showed com-
promised mutant Xist localization and reduced silencing
efficiency. Although random XCI initially occurs in het-
erozygous XistINV/WT cells, the mutant Xist cannot sustain
XCI and cells that initially inactivated this allele are
gradually selected against and lost from the cell population
(Senner et al. 2011). Similar to what was discussed for
repeat C, deletion of repeat D was found to lead to less
severe phenotypes (Wutz et al. 2002), suggesting that the
overall structure of Xist is affected by the inversion.
Another highly conserved region in Xist is exon IV.
Deletion of this exon does not lead to detectable XCI
phenotypes, except for a slight reduction in expression of
the mutant Xist transcript (Caparros et al. 2002). However,
this does not result in skewing such as observed for
mutations in Tsix (Lee and Lu 1999).
Another conserved feature of Xist RNA is its length. A
fair number of non-coding RNAs have been identified,
many of them functioning in the establishment of epige-
netic modifications, imprinting of genes and allele-specific
expression. However, measuring 17 kb in mouse and over
19 kb in humans, Xist is the longest functional non-coding
RNA described, making the poor sequence conservation
even more mysterious. Secondary structure formation and
230 Hum Genet (2011) 130:223–236
123
size may both contribute to Xist function by unknown
mechanisms. Speculatively, these mechanisms include
aggregation and intermolecular interactions, or Xist might
even function as a ribozyme. Finally, the size of Xist
combined with a complicated secondary structure could act
to limit its diffusion through the nucleus and restrict its
localization to the chromosome from which it is tran-
scribed—the nuclear matrix possibly serving as a physical
barrier.
Spreading of Xist
How does Xist recognize and bind to the X chromosome?
In mammals, no specific sequences that designate the X
chromosome for dosage compensation are known. In
Drosophila and C. elegans, however, sequences important
for X chromosome identity have been defined that are
involved in targeting the DCC to the X chromosomes. The
mechanisms of X-recognition, binding and spreading show
striking overlap in these species despite the opposing
effects of dosage compensation (activation vs. silencing)
(Fig. 1a–d). Sites that specify the X chromosome are
necessary in both species because dosage compensation is
regulated by trans-acting factors. For example, although
the roX genes are X-linked in Drosophila, they act in trans
since roX gene expression from autosomal transgenes
drives correct assembly and spreading of the DCC on X,
although autosomal spreading is also observed (Meller and
Rattner 2002). Targeting to the X chromosome is driven by
high affinity DCC binding sites called chromatin entry sites
(CES), which share a 150 bp motif (Oh et al. 2003, 2004).
Although the motif itself is only slightly enriched on the X
chromosome compared with autosomes, its positioning
downstream of active genes is highly specific for the X
chromosome. Higher concentrations of the DCC have been
demonstrated to enable occupation of lower-affinity bind-
ing sites (Fagegaltier and Baker 2004; Park et al. 2002).
Strikingly, the highest affinity binding sites are the roX
genes themselves (Kelley et al. 1999). This suggests that
complexes are assembled at the site of roX RNA tran-
scription, after which mature DCCs can spread to other
sites on the X chromosome (Smith et al. 2001). Interest-
ingly, spreading of the DCC onto autosomal sequences is
highly correlated with gene activity, suggesting a role for
active chromatin modifications, RNA polII or open chro-
matin in DCC spreading (Larschan et al. 2007) (Fig. 1a).
Sequence motifs for DCC binding have also been identified
in C. elegans (McDonel et al. 2006). The sites were map-
ped by extensive analysis of extra-chromosomal arrays
carrying X-sequences for their ability to recruit the DCC
(Csankovszki et al. 2004). Termed rex (recruiting element
on X) sites, they are capable of DCC recruitment when
integrated on autosomes. Their specificity was later
confirmed and extended by ChIP-chip analysis, which
showed preferred binding of the DCC to promoter regions
(Ercan et al. 2007; Jans et al. 2009). The rex sites cooperate
with so-called dox sites (dependent on X), which cannot
recruit the DCC when detached from X, but are essential
for spreading of the DCC (Jans et al. 2009).
The use of trans-acting initiation factors and lack of a
cis-acting factor like Xist in flies and worms results in the
need to target dosage compensation to X chromosomes by
X-specific sequences. Importantly, flies and worms lack an
equivalent of mammalian choice: once the decision to
initiate dosage compensation has been made, all X chro-
mosomes in the nucleus are subjected to dosage compen-
sation. Studies of hermaphrodite worms with aberrant X
chromosome numbers show that, as in mammals, the X:A
ratio determines whether dosage compensation is on or off
(Meyer 2000). However, no choice has to be made since all
worm X chromosomes are subjected to dosage compen-
sation. A similar situation exists in male flies. In contrast,
mammals inactivate a single X and the other X chromo-
some remains active. The cis-specificity of Xist in mam-
mals may be sufficient to recognize which chromosome is
to be inactivated and prevents inactivation in trans. Mono-
allelic expression might be the mechanism that omits the
need for X-specific sequence elements that recruit dosage
compensation elements as in worms and flies. In mammals,
specification of the X chromosome for targeting dosage
compensation may thus not be required. Nevertheless,
sequence elements that promote spreading are potentially
important.
LINE-1 or LINE elements (long interspersed elements)
are retrotransposons that constitute a large part of mam-
malian genomes, e.g., 17% in humans (Cordaux and Batzer
2009). Because of their relatively high density on human X
chromosomes, they have been suggested to play a role in
promoting spreading of Xist (Lyon 1998). Several findings
further support a role for LINEs in XCI. First, Xist does not
spread efficiently when expressed from autosomes, which
are relatively LINE-poor, and spreading is especially
inhibited into LINE-poor autosomal areas (Popova et al.
2006; Tang et al. 2010). Furthermore, LINEs seem to be
expressed specifically from the Xi (Chow et al. 2010), and
Xist interacts with LINE elements directly (Murakami
et al. 2009). Furthermore, a computational approach on
human X chromosomes found that LINE elements are
particularly enriched in the 50-region of genes that are
silenced during XCI (Wang et al. 2006).
The LINE hypothesis remains heavily disputed as many
findings counteract the above. First, LINE enrichment
could merely be a passive and non-functional consequence
of the reduced meiotic recombination rate of the X chro-
mosome compared with autosomes, in view of the lack of
X recombination in the male germline. Whereas LINE
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elements are enriched on human X chromosomes, espe-
cially around the Xic region (Bailey et al. 2000), no such
enrichment is observed for mouse X chromosomes (Chu-
reau et al. 2002). Also, a South American rodent, Oryzomys
palustris, has been reported that appears to lack LINE
elements in its genome, and this is not associated with
more rapid mutations in Xist (Cantrell et al. 2009). Fur-
thermore, LINE-poor areas are generally gene-rich, and
gene-poor areas tend to be LINE-rich. Impaired spreading
on autosomes at LINE-poor areas is now attributed to the
low LINE-density, but could result from selection against
cells that efficiently silence these regions; since these same
regions are also gene-rich, their silencing may severely
affect cell viability. Cells that fail to silence gene-rich
autosomal areas may thus be more efficiently propagated
due to selection effects. Finally, Xist spreading at gene-
poor LINE elements seem to contradict the observation that
hallmarks of XCI are first found on active genes (Marks
et al. 2009). Finally, as discussed above, the cis-acting
properties of Xist may make the need for spread elements
redundant.
Chromatin changes and transcription effects
In mammals, many histone modifications and other chro-
matin changes cooperate to establish and maintain the
silent state. These are well characterized and as mentioned
above, include amongst others H3K27me3, macroH2A
incorporation, H2Aub and DNA methylation. How these
modifications are targeted to specific genes and how others
escape silencing is unknown. In flies and worms, epigenetic
modifications seem to be less extensive, possibly because
dosage compensation here involves fine-tuning of expres-
sion levels to a twofold change instead of global silencing,
therefore, requiring different mechanisms and different
chromatin modifications. In flies, the dosage compensated
X chromosome in males is characterized by increased
acetylation of lysine 16 on histone 4 (H4K16ac), a hall-
mark of active chromatin (Turner et al. 1992). Notably, this
enrichment is biased toward 30-ends of genes, whereas
H4K16ac normally accumulates at 50-gene promoters
(Gelbart et al. 2009; Kind et al. 2008; Smith et al. 2001). It
was recently shown that RNA polII density is also
enhanced at 30-gene ends (Larschan et al. 2011) and the
current model thus proposes that the Drosophila DCC acts
to enhance transcription elongation, rather than initiation.
In addition to the bias toward 30-gene ends, the DCC also
preferably targets active genes for H4K16ac modification
on the X chromosome, even when they are from autosomal
origin and inserted as transgenes on X (Gorchakov et al.
2009). This bias may be responsible for fine-tuning to
twofold increase in expression for differentially expressed
genes.
In C. elegans, where transcription of both hermaphrodite
X chromosomes is reduced by half, no chromatin modifi-
cations associated with the dosage compensated X chro-
mosomes have yet been found (Fig. 1). Depletion of the
histone variant H2A.Z (HTZ-1 in C. elegans) from the X
chromosome is the only nucleosomal change identified so
far. This seems to contribute indirectly to dosage com-
pensation because the relative enrichment on autosomes
prevents spreading of the DCC onto autosomes (Petty et al.
2009). One subunit of the DCC contains SMC (structural
maintenance of chromosomes) family proteins, and thereby
resembles condensin, a protein complex that condenses
chromatin in preparation for cell division. This suggests
that changes in higher order chromatin structure likely play
a role in transcriptional silencing in C. elegans (Csan-
kovszki 2009). Despite the highly different systems, recent
findings show some parallels between mammalian and
C. elegans dosage compensation. First, an SMC protein
was recently found to colocalize with the Xi in mice and
was implicated in DNA methylation (Blewitt et al. 2008).
Furthermore, a recent study showed that one DCC com-
ponent, DPY-30, is also part of the gene activating MLL/
COMPASS complex (Pferdehirt et al. 2011), which stim-
ulates H3K4me3 in mammals (Jiang et al. 2011). Both
complexes bind the same genes in C. elegans despite their
opposing effects on transcription (Pferdehirt et al. 2011).
Speculatively, DPY-30 may be involved in targeting the
DCC to active genes by switching between the two
complexes.
Despite the different mechanisms of dosage compensa-
tion, the preference for targeting active genes seems to be
shared by all three species. In C. elegans, DCC affinity for
genes depends on transcriptional activity (Ercan et al.
2009). The DCC is targeted to active genes in Drosophila
by the chromodomain subunit of MSL3, which recognizes
the active H3K36 trimethyl mark (Larschan et al. 2007;
Sural et al. 2008). Chromatin immunoprecipitation (ChIP)
against H3K27me3 in differentiating mouse ES cells fol-
lowed by high-throughput parallel sequencing revealed that
the H3K27me3 mark appears first at active promoters,
indicating that, also in mammals, active genes are preferred
targets of dosage compensation (Marks et al. 2009). Hence,
some properties of active genes might serve as a basis for
targeting dosage compensation. These properties may
involve active chromatin marks, ongoing transcription by
RNA polII, or a combination of events.
Perspectives
Many questions about X chromosome inactivation in
mammalian species remain to be solved, and knowledge
about dosage compensation in worms and flies may be
helpful to address different points. In mammalian XCI,
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unsolved issues include, for example, the working mech-
anism that underlies the cis-acting specificity of Xist. Also,
it is likely that more activators and inhibitors of dosage
compensation remain to be identified. Furthermore, the role
of LINE elements as cis-acting booster elements for
spreading of Xist needs to be confirmed. Finally, the key
factors that contribute to set the XCI window and to
achieve stable and irreversible silencing need to be eluci-
dated. Identifying these factors would not only provide
more insight in X chromosome dosage compensation, but
potentially also in gene regulation mechanisms in general.
Clearly, X-inactivation research is likely to uncover many
more interesting insights in the future that may well extend
beyond the field of dosage compensation.
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